Northern Trust’s Acer Therapeutics Inc ACER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-22,231
Closed -$18.1K 4602
2023
Q3
$18.1K Hold
22,231
﹤0.01% 4344
2023
Q2
$20.5K Hold
22,231
﹤0.01% 4408
2023
Q1
$16.9K Sell
22,231
-320
-1% -$631 ﹤0.01% 4475
2022
Q4
$56.6K Hold
22,551
﹤0.01% 4253
2022
Q3
$31K Buy
22,551
+3,145
+16% +$4.55K ﹤0.01% 4456
2022
Q2
$24K Buy
19,406
+268
+1% +$561 ﹤0.01% 4597
2022
Q1
$55K Sell
19,138
-344
-2% -$830 ﹤0.01% 4514
2021
Q4
$44K Buy
19,482
+2,822
+17% +$6.55K ﹤0.01% 4613
2021
Q3
$43K Sell
16,660
-3,012
-15% -$7.64K ﹤0.01% 4555
2021
Q2
$57K Sell
19,672
-4,295
-18% -$12.4K ﹤0.01% 4473
2021
Q1
$75K Sell
23,967
-3,381
-12% -$11.5K ﹤0.01% 4334
2020
Q4
$72K Sell
27,348
-3,735
-12% -$10K ﹤0.01% 4181
2020
Q3
$90K Buy
31,083
+814
+3% +$2.63K ﹤0.01% 3986
2020
Q2
$103K Sell
30,269
-35,885
-54% -$101K ﹤0.01% 3912
2020
Q1
$132K Sell
66,154
-8,888
-12% -$32.6K ﹤0.01% 3764
2019
Q4
$301K Sell
75,042
-1,752
-2% -$5.95K ﹤0.01% 3675
2019
Q3
$246K Buy
76,794
+28,481
+59% +$83.5K ﹤0.01% 3707
2019
Q2
$188K Buy
48,313
+9,491
+24% +$181K ﹤0.01% 3838
2019
Q1
$944K Buy
38,822
+5,250
+16% +$124K ﹤0.01% 3378
2018
Q4
$676K Buy
33,572
+1,797
+6% +$41.4K ﹤0.01% 3477
2018
Q3
$980K Buy
+31,775
New +$851K ﹤0.01% 3474
2015
Q3
Sell
-442
Closed -$16K 4343
2015
Q2
$16K Sell
442
-99
-18% -$3.81K ﹤0.01% 4156
2015
Q1
$25K Hold
541
﹤0.01% 4213
2014
Q4
$32K Hold
541
﹤0.01% 4145
2014
Q3
$45K Hold
541
﹤0.01% 4156
2014
Q2
$75K Hold
541
﹤0.01% 4056
2014
Q1
$84K Hold
541
﹤0.01% 3983
2013
Q4
$82K Buy
541
+103
+24% +$16.8K ﹤0.01% 3901
2013
Q3
$80K Buy
438
+303
+224% +$40.5K ﹤0.01% 3852
2013
Q2
$17K Buy
+135
New +$19.7K ﹤0.01% 4016

Other funds holding ACER

Northern Trust's ACER Position: Q4 2023 in Review

Northern Trust sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 22,231 shares — an estimated $18.1K sold.

Northern Trust first reported a position in ACER in Q2 2013 and held it in 30 quarters. The position peaked at $980K in Q3 2018. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.

  • Northern Trust reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
  • Northern Trust sold 22,231 Acer Therapeutics Inc shares in Q4 2023, an estimated $18.1K.
  • Northern Trust first reported a position in Acer Therapeutics Inc in Q2 2013 and held it in 30 quarters.
  • Northern Trust's Acer Therapeutics Inc position peaked at $980K in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.

Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.